Arbutus Biopharma
ABUS
#6260
Rank
A$1.02 B
Marketcap
$5.34
Share price
-7.98%
Change (1 day)
17.31%
Change (1 year)

Earnings for Arbutus Biopharma (ABUS)

Earnings in 2024 (TTM): -A$0.11 Billion

According to Arbutus Biopharma 's latest financial reports the company's current earnings are A$6.17 Million. , an increase over its 2023 earnings that were of -A$0.13 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Arbutus Biopharma from 2008 to 2024

Annual earnings

Year Earnings Change
2024 -A$0.12 Billion-4.02%
2023 -A$0.13 Billion12.05%
2022 -A$0.11 Billion-14.74%
2021 -A$0.13 Billion19.61%
2020 -A$0.11 Billion-61.69%
2019 -A$0.28 Billion171.23%
2018 -A$0.11 Billion-43.58%
2017 -A$0.18 Billion-77.77%
2016 -A$0.81 Billion532.77%
2015 -A$0.13 Billion99.05%
2014 -A$64.24 Million175.82%
2013 -A$23.29 Million-143.7%
2012 A$53.29 M-399.11%
2011 -A$17.82 Million-39.03%
2010 -A$29.23 Million100.55%
2009 -A$14.58 Million-28.56%
2008 -A$20.4 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
A$58.35 M-150.46%๐Ÿ‡บ๐Ÿ‡ธ USA
-A$3.58 Million-96.91% Bahamas